This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pathai, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Archit Khosla: Innovator in Predictive Healthcare Technology
Introduction
Archit Khosla is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of healthcare technology, particularly in the area of predictive analytics for disease management. His innovative work focuses on improving the understanding and treatment of ulcerative colitis.
Latest Patents
Archit Khosla holds a patent for "Systems and methods for predicting disease severity in ulcerative colitis." This patent describes a method, system, or non-transitory computer-readable storage medium for training models to predict ulcerative colitis (UC) severity based on human-interpretable image features extracted from whole-slide images. The process involves accessing a plurality of annotated whole-slide images associated with UC patients, extracting human-interpretable image features, training a statistical model, and storing the trained model on a storage device. This innovative approach aims to enhance the accuracy of disease severity predictions, ultimately benefiting patient care.
Career Highlights
Archit Khosla is currently employed at Pathai, Inc., where he continues to develop cutting-edge technologies in healthcare. His work at Pathai focuses on leveraging artificial intelligence and machine learning to improve diagnostic processes and patient outcomes. With a strong background in both technology and healthcare, Khosla is well-positioned to make a lasting impact in the medical field.
Collaborations
Archit collaborates with talented professionals such as Fedaa Najdawi and Kathleen Sucipto. These partnerships enhance the innovative capabilities of his projects and contribute to the advancement of predictive healthcare technologies.
Conclusion
Archit Khosla is a notable inventor whose work in predictive healthcare technology is paving the way for improved disease management. His patent on predicting ulcerative colitis severity exemplifies his commitment to innovation in the medical field.